New trial aims to spare the rectum in rectal cancer patients

NCT ID NCT06952101

First seen Mar 10, 2026 · Last updated May 17, 2026 · Updated 11 times

Summary

This study tests a personalized, stage-based treatment plan for people with rectal cancer that has not spread. The goal is to avoid removing the rectum when possible, using less invasive surgeries like laparoscopy or robotics to reduce physical and emotional side effects. About 200 participants will be grouped by their cancer stage and receive tailored treatments, with doctors tracking how well organ-sparing approaches work.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECTAL ADENOCARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Email: •••••@•••••

Locations

  • Department of Surgical Oncology - FPO-IRCCS Institute for Cancer Research and Treatment

    RECRUITING

    Candiolo, Turin, 10060, Italy

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

Conditions

Explore the condition pages connected to this study.